Full-Time
Manufacturing System Test Technician
Noah Medical
201-500 employees
Medical robotics system for lung diagnostics
Compensation Overview
$28 - $35/hr
San Jose, CA, USA
In Person
On-site work is required; the listed shift schedules are Monday through Thursday.
Bachelor's
 QA & Testing (1) |
|---|
Get referred to Noah Medical
See people who can refer or advise you
- Proficiency with Windows operating system administration, including Device Manager, network and Internet Protocol configuration, SFTP file transfer, command-line utilities, structured software test procedures, and error logs.
- Basic familiarity with networking concepts, including IP addressing and Ethernet configuration.
- Ability to operate electrical safety test equipment such as HiPot testers, ground bond testers, and leakage current testers, and interpret numeric results against pass/fail criteria.
- Experience working in a regulated environment compliant with ISO 13485 and 21 CFR 820.
- A high school diploma and 3-5 years of hands-on software-driven test systems work experience, or an Associate degree with technical emphasis and at least 2 years of such experience, or a Bachelor of Science degree in Computer Science, Electrical Engineering, Industrial Engineering, or a similar field with 1 year of software-driven test systems experience.
- Knowledge of Good Manufacturing Practices, nonconformance reports, and line clearance procedures.
- English language proficiency.
- Assemble and test medical robotic systems and subassemblies according to established Manufacturing Process Instructions, drawings, and schematics.
- Execute detailed electronic test procedures, record pass/fail results and numeric measurements against defined tolerances, and document them in Device History Records.
- Run diagnostic software and test scripts such as MTS Runner and Nova to validate system function and troubleshoot failed steps.
- Configure and troubleshoot Windows-based test systems, including COM ports, static IP addresses, USB security policies, and SFTP file transfers using WinSCP.
- Edit XML configuration files and re-sign them using command-line utilities during system setup.
- Operate electrical safety test equipment and follow high-voltage safety protocols.
- Monitor subsystem status, such as UPS battery charge, using SNMP and MIB browser tools during extended test cycles.
- Document test results, error codes, and engineering justifications in electronic Device History Records.
- Perform final mechanical assembly steps using basic hand tools.
- Collaborate with engineers to troubleshoot failures, escalate unresolved issues, and support root cause analysis for nonconformances.
- Package medical subassemblies and systems according to established Manufacturing Process Instructions and drawings.
- Install and configure hardware components, including robotic arms, sensors, motors, programmable logic controllers, relays, circuit boards, and cables.
- Install and configure software components, including programming and testing robotic movements and functions.
- Perform system testing and work with engineers to troubleshoot issues.
- Maintain accurate system configuration, test-result, and troubleshooting records in Device History Records while adhering to Good Manufacturing Practices.
- Maintain a clean and organized work area as part of line clearance and lean manufacturing practices.
- Meet standard cycle-time and quality requirements.
- Perform other reasonable assembly, rework, or test duties as required.
- Work the assigned Monday-through-Thursday shift, with either a 5:00 AM-3:30 PM or 3:00 PM-2:00 AM schedule, and stay overtime when required.
NoahMed develops medical robotics systems for pulmonology, focusing on early diagnosis. Its flagship Galaxy System with TiLT+ Technology mitigates CT-to-body divergence to improve diagnostic yield and provides real-time navigation updates in all lung areas. It features an augmented fluoro overlay that guides locating non-visual lesions and a single-use bronchoscope with accessories to reduce cross-contamination and speed turnover, all in a compact, single-cart design for crowded operating rooms. The company differentiates itself through TiLT+ navigation, real-time augmented guidance, and a disposable—rather than reprocessed—bronchoscope setup, aiming to improve diagnostic confidence and efficiency. Its goal is to enhance early lung diagnosis with more reliable guidance, reducing procedure time and improving outcomes for patients in collaboration with interventional pulmonologists.
Company Size
201-500
Company Stage
Series B
Total Funding
$150M
Headquarters
Redwood City, California
Founded
2018
Get referred to Noah Medical
See people who can refer or advise you
Simplify's Take
What believers are saying
- Galaxy II’s commercial launch on August 11, 2026 expands the installed base monetization story.
- Noah says Galaxy surpassed 10,000 procedures globally by April 2026, proving adoption.
- MATCH 2 and Cleveland Clinic data support premium pricing against Intuitive and Olympus rivals.
What critics are saying
- FDA issued a warning letter on April 9, 2025 for quality-system failures.
- FDA posted a Galaxy System recall on November 26, 2025 over password-protected IFUs.
- Auris Health’s trade-secret case still shadows Noah, risking injunctions and delayed product expansion.
What makes Noah Medical unique
- Galaxy II launched August 11, 2026 with HD-DT and CBCT dual-mode imaging.
- Galaxy uses always-on camera and single-use bronchoscope, reducing reprocessing and contamination risk.
- MATCH 2 showed 96.7% diagnostic yield, strengthening Noah Medical’s real-time lesion targeting story.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Legal Services
Pet Insurance
12+ Paid Holidays
15-20 Days of PTO
Paid Parental Leave
In-office Snacks and Beverages
In-office Lunch Stipend
Learning & Development Opportunities
Team Building and Company Organized Social Events
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -3%2 year growth
↑ 0%Noah Medical announces galaxy(tm) II. 11th, August 2026 2 mins read Noah Medical has announced the commercial launch of the Galaxy II software, the next evolution of the company's robotic-assisted bronchoscopy (RAB) platform. The Galaxy II software gives physicians imaging flexibility and procedural control to take on their most complex cases with confidence, advancing what bronchoscopy can deliver across every dimension of the procedure. Lung cancer remains the leading cause of cancer death worldwide, and survival depends heavily on early diagnosis, making the ability to accurately biopsy small, hard-to-reach lung lesions one of the most consequential steps in a patient's path to treatment. At the center of the system is Dual-Mode Imaging, which lets physicians move seamlessly between Galaxy's High- Definition Digital Tomosynthesis (HD-DT) and Cone-Beam CT (CBCT) at any point in a procedure. HD-DT delivers efficiently and effectively across the vast majority of cases at a fraction of the radiation dose, while CBCT is available at the moment a case calls for more. The result puts the imaging decision where it belongs, in the physician's hands. "Galaxy II software puts physicians in control of their imaging strategy for every procedure," said Jian Zhang, founder and CEO of Noah Medical. "By bringing HD-DT, CBCT, and advanced robotic control together in one platform using the Galaxy II software, we let physicians choose what each case requires, enabling them to adapt to each patient's anatomy and reduce radiation exposure while maximizing procedural efficiency." Accurately reaching and sampling small pulmonary lesions remains difficult due to two persistent challenges: CT-to-Body Divergence, where the preoperative CT no longer matches the patient's anatomy during the procedure, and Tool-Tissue Divergence, where a biopsy tool drifts from its intended path even when the catheter is well positioned. Galaxy II software addresses both by uniting navigation, imaging, and real-time confirmation of the lesion and tool in a single platform. "The Galaxy System's unique ability to correct for tool-tissue divergence in real time drives its high diagnostic yield, giving physicians confidence that their biopsy tool is exactly where they intend it," said Dr. Francisco Almeida, Interventional Pulmonologist at City of Hope(R) Cancer Center Atlanta. "Galaxy II software builds on that foundation, enhancing navigation, imaging, and confirmation in a single platform. It puts the choice of imaging modality in the physician's hands, so procedures run more efficiently while also cutting the radiation burden on patients and clinicians."
Noah Medical has launched Galaxy II software for its robotic-assisted bronchoscopy platform. The system features Dual-Mode Imaging, allowing physicians to switch between High-Definition Digital Tomosynthesis and Cone-Beam CT during procedures. The technology addresses challenges in biopsying small lung lesions by combining navigation, imaging, and real-time confirmation in one platform. HD-DT provides imaging at up to 10 times lower radiation dose than CBCT for most cases, whilst CBCT remains available for complex procedures. The Galaxy System demonstrated 96.7% diagnostic yield in the multicentre MATCH II study and 90% yield in routine clinical practice at Cleveland Clinic across 100 consecutive patients. Lung cancer remains the leading cause of cancer death worldwide, with survival heavily dependent on early diagnosis.
MemorialCare Cancer Institute uses first-of-its-kind robotic navigated bronchoscopy for greater precision and accuracy.LAGUNA HILLS, Calif., Aug. 6, 2024 /PRNewswire/ -- MemorialCare Cancer Institute's Lung Cancer Program at Saddleback Medical Center is one of just four hospitals in California equipped with the recently FDA-cleared robotic navigated bronchoscopy system. This new device from NoahMed, Galaxy System, uses integrated tomosynthesis (3D mammography) to navigate to and locate lung nodules, which are small masses in the lungs often tested for cancer.This improved visualization, along with a disposable bronchoscope, enhances precision and accuracy beyond the capabilities of existing technologies. It gives physicians access to often hard-to-reach lesions in the outer third of the lung which are often hard to biopsy. The Galaxy System can biopsy nodules smaller than 2cm, while receiving real-time lesion location updates."Lung cancer is an insidious disease causing far too high a toll on our communities," said Jayne Stewart, executive director, MemorialCare Cancer Institute, MemorialCare Saddleback Medical Center. "The Galaxy System gives physicians trained on the device a clear, direct path to improving patient diagnosis and, in turn, treatment –allowing us to catch lung cancer before it reaches less treatable, advanced stages
Noah MedicalNext-generation robotics company and its CEO recognized separately for pioneering work, innovative new technology, and rapid progressSAN CARLOS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that it has been named a finalist in the prestigious Surgical Robotics Industry Awards 2024 alongside its founder and CEO Dr. Jian Zhang. This joint recognition highlights Noah Medical’s groundbreaking work in endoluminal robotics and Dr. Zhang’s visionary leadership within the industry.Noah Medical is a finalist in the Innovative Start-up category, which honors companies under six years old that have demonstrated significant potential and introduced innovative solutions to enhance surgical procedures and patient outcomes. Dr. Zhang is a finalist in the Industry Leadership category, awarded to those who have demonstrated outstanding business or commercial success, highly effective management, and a track record as a thought leader.Since the beginning of 2023, Noah Medical has announced $150 million in Series B funding , secured FDA clearance for The Galaxy System™, its fully image-integrated solution for robotic navigated bronchoscopy, and launched the platform to commercial and industry acclaim.The company’s proprietary technology is transforming the early identification and diagnosis of lung cancer by making it possible for physicians to overcome traditional imaging and navigation limitations to confidently reach nodules in the outer periphery of the lung
Listen to this articleNoah Medical’s Galaxy is a fully integrated surgical robotics system for navigated bronchoscopy. | Credit: Noah Medical. Medical robotics continues its impressive march forward within mainstream medicine. From new applications to new technologies, the field demonstrated impressive growth over the last year. But there’s still incredible room to grow, and looking ahead to 2024, there are a few clear areas of opportunity